Clinical Trial Update: Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine

View source ↗

Summary

A clinical trial update describes validation of Hemoglobin A1c measurements in patients with inflammatory arthritis treated with sulfasalazine; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Klavs Würgler Hansen | Conditions: Inflammatory Arthritis, Diabetes (DM) | Status: NOT_YET_RECRUITING